[17] [18] Other notable adverse effects included injection site reactions, fatigue, and hypoglycemia in patients taking concomitant insulin or sulfonylureas
Ozempic (semaglutide) is a glucagon-like peptide 1 (GLP-1) receptor agonist used to lower blood sugar levels in patients with type 2 diabetes mellitus to control blood sugar levels in addition to diet and exercise
Obiri, N., Siegel, J., Varricchio, F
Exercise regularly A combination of strength training and cardiovascular exercise helps maximize fat loss
Abruptly stopping the medication often leads to weight regain, so a planned approach is preferable
The peptides osteogenic effects combine with its anti-inflammatory properties to optimize bone repair in fractures, surgeries, and degenerative conditions